<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Introduction: The immediate early response gene X-1 (IEX-1) plays a pivotal role in the regulation of cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, proliferation, differentiation and metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>Deregulation of IEX-1 expression has been confirmed in <z:e sem="disease" ids="C0346429" disease_type="Neoplastic Process" abbrv="">multiple cancers</z:e> in humans, in association with either poor or better prognosis depending on the type and progression stages of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Areas covered: This review summarizes clinical studies of altered IEX-1 expression in ovarian, pancreatic, blood, breast and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:mp ids='MP_0009440'>myeloma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The authors also outline the current understandings of the complex functions of IEX-1 gained from studies with animal models and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines so as to help us comprehend the significance of the clinical findings </plain></SENT>
<SENT sid="4" pm="."><plain>Expert opinion: IEX-1 holds great promise to be a valuable biomarker, either alone or in combination with other genes, for monitoring progression of some <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>IEX-1 expression is highly sensitive to environmental cues and distinct between <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>However, use of IEX-1 as a biomarker remains a significant challenge because too little is understood about the mechanism underlying the diverse activities of IEX-1 and a standardized clinical assay for IEX-1 detection and validation of clinical results across different studies are still critically lacking </plain></SENT>
</text></document>